DICTrank: The largest reference list of 1318 human drugs ranked by risk of drug-induced cardiotoxicity using FDA labeling
Open accessPublished version of a preprint
Abstract
Abstract Drug-induced cardiotoxicity (DICT) is one of the leading causes of drug attrition in clinical trials or withdrawal from the market. Many studies have been conducted to detect DICT in the early stage of drug development and clinical diagnosis, but the success is limited, as evident by the high attrition rate at all clinical phases due to DICT. Most of these efforts, if not all, have focused on specific adverse events and/or mechanisms associated with DICT, such as QT prolongation and hERG-related cardiotoxicity. However, given the broad spectrum of cardiotoxicity, it is necessary to develop a reference drug list with a systematic annotation of DICT potential across a large number of drugs and drug classes. Such a list is essential for developing effective DICT diagnostic biomarkers and early prediction strategies using new approach methods (NAMs), including artificial intelligence (AI). By utilizing labeling documents for FDA (U.S. Food and Drug Administration)-approved drugs, we developed a drug classification scheme to prioritize drugs based on their DICT potential. This resulted in DICTrank, which is the largest dataset of drugs annotated with ranked DICT risk in humans. DICTrank categorizes drugs into four categories of DICT concerns by integrating DICT severity and labeling content. The dataset consists of 1318 drugs, classified as follows: Most-DICT-Concern (341), Less-DICT-Concern (528), No-DICT-Concern (343), and Ambiguous-DICT-Concern (106; lacking sufficient information in the labeling document to determine cardiotoxicity potential). DICTrank covers a wide range of drug therapeutic categories. Using this extensive DICT dataset, we discovered that several therapeutic categories were significantly enriched with drugs of Most-DICT-Concern as well as the association of daily dose with drug class. These categories include antineoplastic agents, sex hormones and modulators of the genital system, anti-inflammatory and antirheumatic products, beta-blocking agents, and cardiac therapy. DICTrank represents the largest drug list for DICT to date, and it could contribute to the development of NAMs and AI models for the early identification of DICT risk during drug development and beyond.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The NCTR has produced drug-induced toxicity benchmark datasets by manually reading and analyzing drug labeling documents, such as DILI, DICT, and DIRIL.
“during the past two decades, the research team at the NCTR has produced several drug-induced toxicity benchmark datasets by manually reading and analyzing drug labeling documents, such as those for drug-induced liver injury (DILI) [9–11], drug-induced cardiotoxicity (DICT) [12], drug-induced renal injury list (DIRIL) [13], and others”
From Leveraging FDA Labeling Documents and Large Language Model to Enhance Annotation, Profiling, and Classification of Drug Adverse Events with AskFDALabel (2025) · cites this paper as [12]
Cites
Can the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167 · see citing works
Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia
Herrmann, J. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0348-1 · Cited by 747 · see citing works
Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management
Curigliano, G., Cardinale, D. M., Dent, S. F., Criscitiello, C., Aseyev, O., Lenihan, D. J., & Cipolla, C. M. (2016) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21341 · Cited by 728 · see citing works
FDA-approved drug labeling for the study of drug-induced liver injury
Chen, M., Vijay, V., Shi, Q., Liu, Z., Fang, H., & Tong, W. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.05.007 · Cited by 406 · see citing works
Self-citationChen, M., Suzuki, A., Thakkar, S., Yu, K., Hu, C., & Tong, W. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.02.015 · Cited by 398 · see citing works
Self-citationCardiovascular Complications of Cancer Therapy
Chang, H., Moudgil, R., Scarabelli, T. M., Okwuosa, T. M., & Yeh, E. T. H. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.09.1096 · Cited by 386 · see citing works
Genetic Variants Associated With Cancer Therapy–Induced Cardiomyopathy
García‐Pavía, P., Kim, Y., Restrepo-Córdoba, M. A., Lunde, I. G., Wakimoto, H., Smith, A. M., Toepfer, C. N., Getz, K., Gorham, J., Patel, P. N., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.037934 · Cited by 358 · see citing works
Comprehensive review of cardiovascular toxicity of drugs and related agents
Mladěnka, P., Applová, L., Patočka, J., Costa, V. M., Remião, F., Pourová, J., Mladěnka, A., Karlíčková, J., Jahodář, L., Vopršalová, M., et al. (2018) · Medicinal Research Reviews · doi:10.1002/med.21476 · Cited by 328 · see citing works
Cardiovascular Complications of Cancer Therapy
Chang, H., Okwuosa, T. M., Scarabelli, T. M., Moudgil, R., & Yeh, E. T. H. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.09.1095 · Cited by 293 · see citing works
Lopez-Sendon, J. L., Álvarez-Ortega, C. A., Zamora, P. M., Soto, A. B., Lyon, A. R., Farmakis, D. T., Cardinale, D. M., Canales, M. Á., Batlle, J. F., Rodríguez, I. R., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa006 · Cited by 289 · see citing works
Women Experience Greater Toxicity With Fluorouracil-Based Chemotherapy for Colorectal Cancer
Sloan, J. A., Goldberg, R. M., Sargent, D. J., Chanes, D. V., Nair, S., Steven, S., Novotny, P. J., Poon, M. A., O’Connell, M. J., & Loprinzi, C. L. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.6.1491 · Cited by 261 · see citing works
Ciallella, H. L., & Zhu, H. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.8b00393 · Cited by 227 · see citing works
Ferri, N., Siegl, P. K. S., Corsini, A., Herrmann, J., Lerman, A., & Benghozi, R. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.03.005 · Cited by 207 · see citing works
Computational determination of hERG-related cardiotoxicity of drug candidates
Lee, H., Yu, M., Kazmi, S. R., Oh, S. Y., Rhee, K., Bae, M., Lee, B. H., Shin, D., Oh, K., Ceong, H.-T., et al. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-2814-5 · Cited by 162 · see citing works
Toward a broader view of mechanisms of drug cardiotoxicity
Mamoshina, P., Rodríguez, B., & Bueno‐Orovio, A. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100216 · Cited by 145 · see citing works
Thakkar, S., Li, T., Liu, Z., Wu, L., Roberts, R., & Tong, W. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2019.09.022 · Cited by 140 · see citing works
Self-citationPredicting compound activity from phenotypic profiles and chemical structures
Moshkov, N., Becker, T., Yang, K., Horváth, P., Dančík, V., Wagner, B. K., Clemons, P. A., Singh, S., Carpenter, A. E., & Caicedo, J. C. (2023) · Nature Communications · doi:10.1038/s41467-023-37570-1 · Cited by 116 · see citing works
Feenstra, J., Grobbee, D. E., Remme, W. J., & Stricker, B. H. C. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00006-6 · Cited by 111 · see citing works
Haghighi, M., Caicedo, J. C., Cimini, B. A., Carpenter, A. E., & Singh, S. (2022) · Nature Methods · doi:10.1038/s41592-022-01667-0 · Cited by 109 · see citing works
Murphy, S., & Roberts, R. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.10.031 · Cited by 93 · see citing works
Drug Withdrawal Due to Safety: A Review of the Data Supporting Withdrawal Decision
Craveiro, N. S., Lopes, B. S., Tomás, L., & Almeida, S. F. (2019) · Current Drug Safety · doi:10.2174/1574886314666191004092520 · Cited by 87 · see citing works
Pang, L., Sager, P. T., Yang, X., Shi, H., Sannajust, F. J., Brock, M., Wu, J. C., Abi‐Gerges, N., Lyn‐Cook, B. D., Berridge, B. R., et al. (2019) · Circulation Research · doi:10.1161/circresaha.119.315378 · Cited by 74 · see citing works
Cardiotoxicity screening: a review of rapid-throughput in vitro approaches
Li, X., Zhang, R., Zhao, B., Lossin, C., & Cao, Z. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1651-1 · Cited by 69 · see citing works
cardioToxCSM : A Web Server for Predicting Cardiotoxicity of Small Molecules
Iftkhar, S., de Sá, A. G. C., Velloso, J. P. L., Al‐Jarf, R., Pires, D. E. V., & Ascher, D. B. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c00822 · Cited by 56 · see citing works
The right dose for every patient: a key step for precision medicine
Peck, R. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.22 · Cited by 55 · see citing works
Cardionomics: a new integrative approach for screening cardiotoxicity of drug candidates
Gwathmey, J. K., Tsaioun, K., & Hajjar, R. J. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250902932915 · Cited by 52 · see citing works
Cai, C., Fang, J., Guo, P., Wang, Q., Hong, H., Moslehi, J. J., & Cheng, F. (2018) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.7b00641 · Cited by 52 · see citing works
Ye, L., Ngan, D. K., Xu, T., Liu, Z., Zhao, J., Sakamuru, S., Zhang, L., Zhao, T., Xia, M., Simeonov, A. M., et al. (2022) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2022.116250 · Cited by 47 · see citing works
Self-citationCardiotoxicity following Bupropion Overdose
Druteika, D., & Zed, P. J. (2002) · Annals of Pharmacotherapy · doi:10.1345/aph.1c045 · Cited by 43 · see citing works
Drug-specific risk of severe QT prolongation following acute drug overdose
Campleman, S. L., Brent, J., Pizon, A. F., Shulman, J., Wax, P. M., Manini, A. F., & on behalf of the Toxicology Investigators’ Consortium (ToxIC) (2020) · Clinical Toxicology · doi:10.1080/15563650.2020.1746330 · Cited by 41 · see citing works
Drug-Induced Cardiovascular Disorders
Murphy, C. A., & Dargie, H. J. (2007) · Drug Safety · doi:10.2165/00002018-200730090-00005 · Cited by 39 · see citing works
Black box warnings in prescription drug labeling: results of a survey of 206 drugs.
Beach, J. E., Ga, F., Bormel, F. G., & Sasinowski, F. J. (1998) · PubMed · Cited by 39 · see citing works
Drug-Induced Rhabdomyolysis Atlas (DIRA) for idiosyncratic adverse drug reaction management
Wen, Z., Yu, L., Hao, Y., Delavan, B., Huang, R., Mikailov, M., Tong, W., Li, M., & Liu, Z. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.06.006 · Cited by 38 · see citing works
Self-citationDrug-induced fatal arrhythmias: Acquired long QT and Brugada syndromes
Turker, I., Ai, T., Itoh, H., & Horie, M. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.05.001 · Cited by 36 · see citing works
Assessment of nonsteroidal anti-inflammatory drug-induced cardiotoxicity
Singh, B. K., Haque, S. E., & Pillai, K. K. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.856881 · Cited by 34 · see citing works
How the US Food and Drug Administration defines and detects adverse drug events
Trontell, A. E. (2001) · Current Therapeutic Research · doi:10.1016/s0011-393x(01)80070-9 · Cited by 30 · see citing works
Severe Cardiac Toxicity Induced by Cancer Therapies Requiring Intensive Care Unit Admission
Montisci, A., Palmieri, V., Liu, J. E., Vietri, M. T., Cirri, S., Donatelli, F., & Claudio Napoli, A. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.713694 · Cited by 27 · see citing works
Drug-induced QT Prolongation Atlas (DIQTA) for enhancing cardiotoxicity management
Li, S., Xu, Z., Guo, M., Li, M., & Wen, Z. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.10.009 · Cited by 25 · see citing works
Dokmanovic, M., King, K. E., Mohan, N., Endo, Y., & Wu, W. J. (2017) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2017.1337746 · Cited by 23 · see citing works
Coverage of FDA Medication Boxed Warnings in Commonly Used Drug Information Resources
Cheng, C. M. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.91 · Cited by 21 · see citing works
Assessment of Cardiotoxicity With Stem Cell-based Strategies
Stoter, A. M. S., Hirt, M. N., Stenzig, J., & Weinberger, F. (2020) · Clinical Therapeutics · doi:10.1016/j.clinthera.2020.08.012 · Cited by 16 · see citing works
Braña, I., Zamora, E., & Tabernero, J. M. (2012) · Springer eBooks · doi:10.1007/978-0-85729-787-7_15 · Cited by 3 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Seal, S., Spjuth, O., Hosseini-Gerami, L., García-Ortegón, M., Singh, S., Bender, A., & Carpenter, A. E. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.3c01834 · Cited by 50 · see citing works
ADMET-AI Enables Interpretable Predictions of Drug-Induced Cardiotoxicity
Mukherjee, S., Swanson, K., Walther, P., Shivnaraine, R. V., Leitz, J., Pang, P. D., Zou, J., & Wu, J. C. (2025) · Circulation · doi:10.1161/circulationaha.124.070413 · Cited by 25 · see citing works
Quantitative systems toxicology: modelling to mechanistically understand and predict drug safety
Goldring, C. E., Russomanno, G., Pin, C., Trairatphisan, P., Beattie, K. A., Fisher, C. P., Piñero, J., Brennan, R., Clausznitzer, D., Copple, I. M., et al. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01308-z · Cited by 21 · see citing works
Gambacorta, N., Mastrolorito, F., Togo, M. V., Amenduni, V., Mele, M., Liantonio, A., Mele, A., Luca, A. D., Altomare, C., Belgiovine, V., et al. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117575 · Cited by 19 · see citing works
Text summarization with ChatGPT for drug labeling documents
Ying, L., Liu, Z., Fang, H., Kusko, R. L., Wu, L., Harris, S., & Tong, W. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.104018 · Cited by 18 · see citing works
Self-citationWu, L., Fang, H., Qu, Y., Xu, J., & Tong, W. (2025) · Drug Safety · doi:10.1007/s40264-025-01520-1 · Cited by 20 · see citing works
Self-citationTirgar, P., Vikstrom, A., Sepúlveda, J. M. R., Srivastava, L. K., Amini, A., Tabata, T., Higo, S., Bub, G., & Ehrlicher, A. J. (2024) · Small · doi:10.1002/smll.202409571 · Cited by 17 · see citing works
Wu, L., Xu, J., Thakkar, S., Gray, M., Qu, Y., Li, D., & Tong, W. (2024) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2024.105613 · Cited by 16 · see citing works
Self-citationMa, C., & Wolfinger, R. D. (2024) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.4c00134 · Cited by 9 · see citing works
UniTox: Leveraging LLMs to Curate a Unified Dataset of Drug-Induced Toxicity from FDA Labels
Silberg, J., Swanson, K., Simon, E. P., Zhang, A., Ghazizadeh, Z., Ogden, S., Hamadeh, H. K., & Zou, J. (2024) · neural information processing systems · doi:10.52202/079017-0385 · Cited by 9 · see citing works
Li, T., Qu, Y., Chen, A., Thakkar, S., Li, D., & Tong, W. (2025) · Toxicological Sciences · doi:10.1093/toxsci/kfaf135 · Cited by 7 · see citing works
Self-citationDICTrank Is a Reliable Dataset for Cardiotoxicity Prediction Using Machine Learning Methods
Qu, Y., Li, T., Liu, Z., Tong, W., & Li, D. (2025) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.4c00428 · Cited by 7 · see citing works
Self-citationAnti-Trypanosoma cruzi Potential of New Pyrazole-Imidazoline Derivatives
de Oliveira, E. C., Lara, L. D. S., Orlando, L. M. R., Lanera, S. D. C., de Souza, T. P., Figueiredo, N. D. S., Paes, V. B., Mazzochi, A. C., Fernandes, P. H. M., dos Santos, M. S., et al. (2025) · Molecules · doi:10.3390/molecules30153082 · Cited by 7 · see citing works
Seal, S., Spjuth, O., Hosseini-Gerami, L., García-Ortegón, M., Singh, S., Bender, A., & Carpenter, A. E. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.15.562398 · Cited by 7 · see citing works
Mixture of experts for multitask learning in cardiotoxicity assessment
Viganò, E. L., Iwan, M., Colombo, E., Ballabio, D., & Roncaglioni, A. (2025) · Journal of Cheminformatics · doi:10.1186/s13321-025-01072-7 · Cited by 5 · see citing works
Pandey, S. K., & Roy, K. (2025) · In Silico Research in Biomedicine · doi:10.1016/j.insi.2025.100039 · Cited by 4 · see citing works
Agarwal, D., Sharma, A., & Garg, P. (2026) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.5c00369 · Cited by 3 · see citing works
Cardiotoxicity adverse outcome pathway network: towards mechanistic and quantitative modelling
Ladeira, L., Barnes, D. A., Masereeuw, R., Geris, L., & Staumont, B. (2026) · Frontiers in Toxicology · doi:10.3389/ftox.2026.1781536 · Cited by 3 · see citing works
Is ChatGPT Ready for Public Use in Organ-Specific Drug Toxicity Research?
Connor, S., Wu, L., Roberts, R. A., & Tong, W. (2025) · Drug Discovery Today · doi:10.1016/j.drudis.2025.104297 · Cited by 4 · see citing works
Self-citationQuantitative Structure–Activity Relationship Models to Predict Cardiac Adverse Effects
Mou, Z., Volarath, P., Racz, R., Cross, K. P., Girireddy, M., Chakravarti, S., & Stavitskaya, L. (2024) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.4c00186 · Cited by 2 · see citing works
Machine Learning for Predicting Human Drug-Induced Cardiotoxicity: A Scoping Review
Han, J., Kim, M., Kim, H. W., Choi, K., Ju, S., & Kim, M. G. (2025) · Toxics · doi:10.3390/toxics13121087 · Cited by 2 · see citing works
de Lima, J. A. L., Franco, L. S., & Lima, L. M. (2026) · ACS Omega · doi:10.1021/acsomega.5c08828 · Cited by 2 · see citing works
Non-clinical cardiovascular safety testing: Current status, gaps and emerging trends
Hoffmann, P., & Pugsley, M. K. (2025) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2025.108403 · Cited by 1 · see citing works
Hassanein, E. H. M., El‐Ghafar, O. A. M. A., Alnasser, S. M., Alruhaimi, R. S., Althagafy, H. S., Atwa, A. M., & Mahmoud, A. M. (2026) · Tissue and Cell · doi:10.1016/j.tice.2026.103452 · Cited by 1 · see citing works
Huang, Y., Liu, H., Tong, C., Wang, Z., Xu, M., Dong, M., Rao, R., Wang, X., Feng, W., Hu, Z., et al. (2026) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-026-06142-z · Cited by 1 · see citing works
Gu, T., Wang, G., van den Oord, E. J. C. G., Goldman, E., Yang, C., Xie, N., Yao, L., Wang, C.-Y., Jablonski, M. M., Ray, K., et al. (2024) · The AAPS Journal · doi:10.1208/s12248-024-00964-0 · Cited by 1 · see citing works
Cai, Y., Luo, S., Lin, S., Huang, X., Wang, X., Yang, L., Xu, X., & Weng, X. (2025) · Scientific Reports · doi:10.1038/s41598-025-23217-2 · Cited by 1 · see citing works
Cai, Y., Luo, S., Lin, S., Huang, X., Wang, X., Yang, L., Xu, X., & Weng, X. (2025) · Research Square · doi:10.21203/rs.3.rs-6213342/v1
Kalian, A. D., Silva, A. C., Lee, J., Dorne, J. L. C. M., Potter, C., Benfenati, E., Osborne, O. J., Guo, M., & Högstrand, C. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.27.672581
Pizzarella, D., Neuman, K. E., Burson, N., Koppes, A. N., & Koppes, R. A. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.04.674300
Miniaturized Electromechanical Biosensor for Preclinical Cardiac Drug ScreeningPreprint
Lee, D., Sun, H., Li, L., Shanmugasundaram, A., Kim, E., & Lee, B. (2025) · Research Square · doi:10.21203/rs.3.rs-7725479/v1
Gel‐Amin for Improving Extracellular Recordings of Cardiomyocytes in a 3D Microphysiological System
Pizzarella, D., Neuman, K. E., Burson, N., Koppes, A. N., & Koppes, R. A. (2025) · Advanced Electronic Materials · doi:10.1002/aelm.202500623
Hansen, J., Martinez, P., Yadaw, A. S., Xiong, Y., Racz, R., Pacanowski, M. A., Hopkins, L. L., King, N. M. P., Abernethy, D., Sobie, E. A., et al. (2026) · Database · doi:10.1093/database/baag003
Kinome profiling allows examination and prediction of kinase inhibitor cardiotoxicityPreprint
Tabet, J. S., Joisa, C. U., Jensen, B. C., & Gomez, S. M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.03.716310
Cortina, J. M. A., Schut, M. C., & Tatonetti, N. P. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.06.723121
Iwan, M., Roncaglioni, A., & Grisoni, F. (2026) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6c00418
Liu, J., Guo, W., Patterson, T. A., & Hong, H. (2026) · Royal Society of Chemistry eBooks · doi:10.1039/9781837070206-00462
Zhang, Y., Liu, Y., Bi, G., & Chen, J. (2026) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6c00190
Dikyol, C., Alsaafin, A., Bodenstein, D. F., Beeghly, G. F., Popovic, A. M., Jiang, R., & Radisic, M. (2026) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2026.115972
Karami, N., Knafl, S., Wanzenboeck, H. D., & Prado‐Lòpez, S. (2026) · Frontiers in Electronics · doi:10.3389/felec.2026.1886715
Sips, F. L. P., Bisotti, M.-A., Torchia, M., Carbone, V., Gambacorta, N., Belgiovine, V., Ciriaco, F., Nicolotti, O., Trénor, B., Sáiz, J., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27209312
- Authors
- Qu, Y., Li, T., Liu, Z., Li, D., & Tong, W.
- Affiliations
- University of Arkansas at Little Rock (US)
- National Center for Toxicological Research (US)
- Corresponding author
- Li, Dongying
- Tong, Weida
- Venue
- Drug Discovery Today
- Publisher
- Elsevier BV
- Published
- 2023-11
- Volume
- 28
- Issue
- 11
- Pages
- 103770
- ISSN
- 1359-6446 (ISSN-L)
- OpenAlex
- W4386697152
- Cited by
- 41
- References
- 42
- Citations by year
- 2026: 14 · 2025: 18 · 2024: 8 · 2023: 1
- FWCI
- 2.15
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Drug Discovery Today (publishedVersion, cc-by-nc)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed (publishedVersion)
- Funders
- Medizinischen Hochschule Hannover
- U.S. Food and Drug Administration (S00863, E07808.01)
- Oak Ridge Institute for Science and Education
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Chemotherapy-induced cardiotoxicity and mitigation
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Physical Sciences › Computer Science › Computational Theory and Mathematics › Computational Drug Discovery Methods
- Keywords
- drug-induced cardiotoxicity, FDA drug labeling, adverse cardiac events, anticancer agents, sex hormones, beta-blockers, cardiac therapy, drug development risk
- MeSH terms
- Antineoplastic Agents, Humans, Cardiotoxicity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
